Language selection

Search

Patent 1292713 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1292713
(21) Application Number: 553599
(54) English Title: PROCESS FOR PRODUCING ANTIBIOTIC SALINOMYCIN
(54) French Title: PROCEDE DE PRODUCTION D'UN ANTIBIOTIQUE, LA SALINOMYCINE
Status: Deemed expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 195/101
(51) International Patent Classification (IPC):
  • C12P 1/00 (2006.01)
  • C12N 1/20 (2006.01)
  • C12P 17/06 (2006.01)
  • C12P 19/54 (2006.01)
(72) Inventors :
  • BERNIK, JANEZ (Yugoslavia/Serbia and Montenegro)
  • IVANOVIC, RADE (Yugoslavia/Serbia and Montenegro)
  • POKORNY, VLADIMIR (Yugoslavia/Serbia and Montenegro)
  • SOKOLIC, MILENKO (Yugoslavia/Serbia and Montenegro)
  • BENICKI, NEDA (Yugoslavia/Serbia and Montenegro)
  • POKORNY, MIROSLAV (Yugoslavia/Serbia and Montenegro)
(73) Owners :
  • BERNIK, JANEZ (Not Available)
  • IVANOVIC, RADE (Not Available)
  • POKORNY, VLADIMIR (Not Available)
  • SOKOLIC, MILENKO (Not Available)
  • BENICKI, NEDA (Not Available)
  • KRKA, TOVARNA ZDRAVIL, N.SOL.O. (Yugoslavia/Serbia and Montenegro)
  • POKORNY, MIROSLAV (Not Available)
(71) Applicants :
(74) Agent: BORDEN LADNER GERVAIS LLP
(74) Associate agent:
(45) Issued: 1991-12-03
(22) Filed Date: 1987-12-04
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
P 2238/86 Yugoslavia/Serbia and Montenegro 1986-12-24

Abstracts

English Abstract






ABSTRACT

There is disclosed a biosynthesis process for producing
antibiotic salinomycin by means of producing strains of the
microorganism Streptomyces albus, which are derived from the
strain ATCC 21838. The microorganism is cultivated under
submersed aerobic conditions in a nutrient medium, containing
an organic carbon source, a nitrogen source, mineral salts,
the amino acid methionine and small quantities of vitamins,
either D-biotin or pyridoxin (B6). By the presence of vitamins
and methionine, a greater and more stable yield of the
antibiotic is achieved more quickly, which makes the process
shorter. As anti-foaming agents there are used vegetable oils
and silicone type anti-foaming agents. From the fermented
broth the antibiotic is isolated in a standard manner.


Claims

Note: Claims are shown in the official language in which they were submitted.



- 8 -
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:

1. A process for producing antibiotic salinomycin by means of the
fermentation of the microorganism Streptomyces albus ATCC 21839,
characterized in that said microorganism is cultivated under
submersed aerobic conditions at a pH from 5.5 to 6.5 and a
temperature from 26°C to 29°C at first in the vegetative phase
uns subsequently in the fermentation phase in a nutrient medium
consisting of a carbon source, a nitrogen source, mineral
salts, the amino acid DL-methionine from 0.01 to 0 15 % and/or
vitamin D-biotin from 10 to 20 µg/ml and/or vitamin B6 from 5
to 10 µg/ml, provided that vitamin D-biotin and vitamin B6 are
not simultaneously present in the nutrient medium.

2. Process according to claim 1, characterized in that as a carbon
source there are used starch, vegetable oils, molasses.

3. Process according to claim 1, characterized in that as a
nitrogen source there are used soya bean meal, (NH4)2SO4, corn
steep liquor, NH4Cl.

4. Process according to claim 1, characterized in that as mineral
salts there are used sulfates, phosphates, chlorides, carbonates
of sodium, potassium, calcium, magnesium.

5. Process according to claim 1, characterized in that an anti-

foaming agent is present and is a vegetable oil or a silicone type
anti-foaming agent.

Description

Note: Descriptions are shown in the official language in which they were submitted.


7~3




PROCESS FOR PRODUCING ANTIBIOTIC SALINOMYCIN

The present invertion relates to an improved process for
producing antibiotic salinomycin by fermentation by means of
the strain of the microorganism Streptomyces albus, deposited
in the collection of microorganisms American Type Culture
Collection, Rockville, USA, No. ATCC 21838, and in the collection
of microorganisms Fermentation Research Institute, Chibe,
FERM-P No. 419, Japan.
It is well-known that salinomycin is produced by means of
various strains of the microorganism Streptomyces albus in
aerobic growth conditions in nutrient media containing an
organic carbon source, such as starch, soya bean oil, glucose,
a nitrogen source, such as ammonium sulfate, ammonium chloride,
and mineral salts, such as CaC03, KH2P04, NaCl, MgS04.
Small quantities of the antibiotic salinomycin in the fermentation
broth and high costs of the composition of the nutrient medium
continually stimulate the search for better colutions with a
greater yield and cheaper production.
A salimomycin molecule i~ very complicated and belongs to
so-called polyether cyclic structures with a greater number of
methyl and etyhl side radicals.
Chemically, polyether antibiotics are derivatives of polyhydroxy-
fatty acids with a branched chain. The biosynthesis of salinomycin
is probably started from acetate, propionate and butyrate
precursors via the polyketide way. Of course, other similar
ways are not excluded. Thus, different oils are the basis of
nutrient media in cultivating said microorganism. Owing to the
large quantity of oils in the nutrient medium, there is necessary

~;~''t27-13
-- 2 --


a strong aeration and stirring, which gives rise to strong
foaming, which can only be reduced by a special silicone type
anti-foaming agent.
The antibiotic salinomycin and ~he microorganism ATCC 21838,
which produces said antibiotic,were obtained for the first time
in 1972 in the Japanese company Kakem Chemical Co. (JP patent
21553). Variants of the first process are patented, too. The
yields, however, are very low, 100 to 500 /ug/ml.
~ater on, a novel sophisticated multi-stage process with novel
mutants was patented, with yields even up to 60,000 ~g/ml. The
nutrient media contained even up to 25 % of oil, which is very
unusual for all known fermentations (EP patent 0 000 037). In
said process a special silicone type antifoaming agent KM-68-2F
(Shinetsu Chemical Industry Co. Ltd.) was used.
In our research we have found that one part of the methyl side
groups originates from amino acid methionine. Microorganisms
obtain said acid in common nutrient media by means of soya bean
meal hydrolysis. Our research has shown that the biosynthesis
of salinomycin can be strongly stimulated by methionine. The
stimulation is much stronger in the presence of vitamins, which
are indispensable for trans-methylating and carboxylating
enzyme reactionq. Said vitamins are preferably vitamin D-biotin
and pyridoxin (vitamin B6).
On the basis of the above discovery, there was prepared a
composition of a fermentation substrate comprising a carbon
source ~soya bean oil, mollasses, starch), a nitrogen source
(soya bean meal, (NH4)2SO4), inorganic salts (KCl, NaCl, CaCO3,
KH2PO4), the amino acid DL-methionine and/or vitamin H, i.e.
D-biotin, or vitamin B6. With such a composition of the nutrient
medium, there are achived greater yields, even for 100 %, in
the same time and under the same conditions, whereas the foaming
can be reduced by means of cheaper anti-foaming agents.

2713
- 3 -

It is interesting that the simultaneous presence of both vitamins
in the nutrient medium exhibits inhibitory action upon
the biosynthesis of salinomycin.
The process for producing antibotic-salinomycin; by means of the
fermentation of the microorganism Streptomyces albus ATCC 21839
is characterized in that said microorganism is cultivated under
submersed aerobic conditions at a pH from 5.5 to 6.5 and a
temperature from 26C to 29C at first in the vegetative phase
and subsequently in the fermentation phase in a nutrient medium
consisting of a carbon source, a nitrogen source, mineral
salts, the amino acid DL-methionine from 0.01 to 0.15 % and/or
vitamin D-biotin from 10 to 20 /ug/ml and/or vitamin B6 from 5
to 10 /ug/ml, provided tnat vitamin D-biotin and vitamin B6 are not
simultaneously present in the nutrient medium.
In the vegetative phase it is cultivated for e.g. 40 to 60 hours
and in the fermentation phase for e.g. 110 to 210 hours.
The following table shows the yields of salinomycin on laboratory
scale.
Nutrient medium Yield: /ug/ml/200 h
standard medium~ 3000
standard medium + 0.01 % methionine 4000
standard medium + 0.01 % methionine
+ 20 /ug/ml D biotin 6000
standard medium + 0.01 % methionine
+ 10 /ug/ml vitamin B6 4500
standard medium + 0.01 % methionine
+ 20 /ug/ml D-biotin
+ 10 /ug/ml vitamin B6 1700

compdsition of the medium as in Example 1

12.~ 713
-- 4 --


In case of a stronger foaming of the fermentation medium, there
are used different anti-foaming agents, such as vegetable oils,
s~licone type anti-foaming agents etc.
The antibiotic is isolated from the fermented broth in a standard
manner.
As mentioned above, the patent and other technical literature
teaches that the foam can only be successfully destroyed with a
special silicone type anti-foaming agent (KM-68-2P, Shinetsu
Chemical Industry, Japan).
In the present process the composition of the medium is such
that no strong foaming takes place; if, however, a foaming
appears, it can be destroyed with other, cheaper anti-foaming
agents.
The concentration of antibiotic salinomycin in the broth is
determined by a bio-test method by means of the microorganism
S. cereus.
The invention is illustrated by the following Examples and in
no way limited thereto.

i3
-- 5 --

Example 1
The microorganism Streptomyces albus 80614 (ATCC 21832) is
cultivated on slant agar in a nutrient medium of the following
composition:
meat extract 10 g
yeast extract 4 g
glucose ~4 g
agar 20 g
water ad1000 ml
pH = 5.8 to 6.0; after sterilization 6.2 to 6.4.
The nutrient medium is previously sterilized at 120C for
20 minutes. To the nutrient medium thus prepared, a suspension
of spores of Streptomyces albus is added and said suspension is
incubated a 28C for 8 to 10 days. The sporulated mycelium,
which grows up on the slant agar, is resuspended in 0.1 %
Tween 80 (10 ml). The suspension so prepared is added to a
vegetative nutrient medium of the following composition:
glucose . 4 %
soya bean meal 1 %
yeast extract 0.5 %
ground CaC03 0.2 %
water ad 100 %
The pH of the nutrient medium after sterilization is 6.6 to

The vegetative phase of microorganism growth lasts up to 48
hours at a temperature of 28C at 220 rpm and is used as inoculum;
the pH of inoculum is 6.4 to 6.8.
A fermentation nutrient medium is inoculated with S to 6 vol %
of the vegetative culture. The fermentation substrate has the
following composition:
soya bean oil 10 %
soya bean meal 1 %
maize starch 0.5 %

lZ~Z'~i3
-- 6 --


(NH4)2SO4 0.3 %
KCl 0.2 %
NaCl 0.2 %
KH2P04 0.02 %
3 0.5 %
MgS04 0.01 %
DL-methionine 0.01 %
water ~ ad 100 %
The fermentation substrate is sterilized at 120C for 30 minutes,
the pH after the sterilization being 7.5. After the fermentation
is completed, i.e. after 200 to 210 hours at 28C, the salinomycin
content in the broth ;s 4000 /ug/ml. During the fermentation
the concentration of the oil in the nutrient medium is continuousl~
kept between 3 and 4 % and the pH at 5.8 with a 10 % ammonia
solution. The foam is destroyed with the silicone type anti-
foaming agent 1510 Dow Corning.

Example 2
It is proceeded as in Example 1 with the exception that the
fermentation nutrient medium additionally contains the vitamin
D-biotin in the end concentration of 20 /ug/ml. After the
fermentation is completed in 200 hours, the yield of salinomycin
is 6000 yg/ml.

Example 3
It is proceeded as in Example 1 with the exception that the
fermentation nutrient medium additionally contain~ vitamin B6
in a concentration of 10 /ug/ml. After the fermentation is
completed in 200 hours, the yield of salinomycin is 4500 /ug/ml.

Example 4
It is proceeded as in Example 2, only that the composition of
the fermentation nutrient medium is as follows:
soya bean oil 10 %
soya bean meal 1 %

Z713
-- 7 --

corn steep liquor 1 %
molasses 1 %
DL-methionine 0.01 %
D-biotin 0.002 %
NH4Cl 0.11 %
3 0.5 %
NaCl 0.2 %
KCl ` 0.2 %
KH2P04 0.02 %
MgS04 0.01 %
water ~ ad 100-%
After the fermentation is completed in 190 hours, the yield of
salinomycin is 8000 ~g/ml.

Representative Drawing

Sorry, the representative drawing for patent document number 1292713 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1991-12-03
(22) Filed 1987-12-04
(45) Issued 1991-12-03
Deemed Expired 1996-06-03

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1987-12-04
Registration of a document - section 124 $0.00 1988-03-14
Maintenance Fee - Patent - Old Act 2 1993-12-03 $100.00 1993-11-12
Maintenance Fee - Patent - Old Act 3 1994-12-05 $100.00 1994-11-28
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BERNIK, JANEZ
IVANOVIC, RADE
POKORNY, VLADIMIR
SOKOLIC, MILENKO
BENICKI, NEDA
KRKA, TOVARNA ZDRAVIL, N.SOL.O.
POKORNY, MIROSLAV
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1993-10-23 1 5
Claims 1993-10-23 1 32
Abstract 1993-10-23 1 21
Cover Page 1993-10-23 1 15
Description 1993-10-23 7 194
Fees 1994-11-28 1 40
Fees 1993-11-12 1 26